Quarterly ResultJul 30, 2026, 04:43 PM
Merit Medical Q2 Net Sales $418.8M, EPS $0.65; Acquires View Point
AI Summary
Merit Medical Systems reported strong financial results for Q2 2026, with net sales increasing by 9.5% to $418.8 million and diluted EPS rising by 20.4% to $0.65. For the six months ended June 30, 2026, net sales grew 8.5% to $800.7 million and diluted EPS increased 29.1% to $1.33. The company also completed the acquisition of View Point Medical for an upfront payment of $90 million and divested its DualCap product line for $28 million, generating a pre-tax gain of $12.5 million.
Key Highlights
- Q2 2026 net sales increased 9.5% to $418.8 million from $382.5 million in Q2 2025.
- Q2 2026 diluted EPS rose 20.4% to $0.65 from $0.54 in Q2 2025.
- Six-month 2026 net sales grew 8.5% to $800.7 million from $737.8 million in 2025.
- Six-month 2026 diluted EPS increased 29.1% to $1.33 from $1.03 in 2025.
- Acquired View Point Medical for $90 million upfront cash on April 1, 2026.
- Divested DualCap product line for $28 million, realizing a $12.5 million pre-tax gain.
- Net cash provided by operating activities was $109.9 million for six months 2026.
- Total assets increased to $2.86 billion as of June 30, 2026.
Price Impact
More from MMSI